Science Corp
@science.xyz
Building a brighter tomorrow enabled by neural engineering
We’re grateful for Prof. Souied’s participation in our clinical trials and co-authorship of The New England Journal of Medicine’s peer-reviewed original paper on Science’s PRIMA brain-computer interface (BCI) retinal implant.
Read more in TIME: time.com/7330887/brai...
Read more in TIME: time.com/7330887/brai...
Computer Chips in Our Bodies Could Be the Future of Medicine
The brain-computer interface is real. It's changing lives—and could soon change the world.
time.com
November 8, 2025 at 4:28 PM
We’re grateful for Prof. Souied’s participation in our clinical trials and co-authorship of The New England Journal of Medicine’s peer-reviewed original paper on Science’s PRIMA brain-computer interface (BCI) retinal implant.
Read more in TIME: time.com/7330887/brai...
Read more in TIME: time.com/7330887/brai...
Join our patient registry for more information: patients.science.xyz?utm_campaign...
Patient Registry | Science Corporation
Join the Science Patient Registry to be considered for participation in our vision loss research studies.
patients.science.xyz
November 3, 2025 at 9:59 PM
Join our patient registry for more information: patients.science.xyz?utm_campaign...
Read more from Moorfields: www.moorfields.nhs.uk/about-us/new...
Pioneering eye device restores reading vision to blind eyes - Moorfields Eye Hospital
www.moorfields.nhs.uk
November 3, 2025 at 9:58 PM
Read more from Moorfields: www.moorfields.nhs.uk/about-us/new...
Learn more about PRIMA here: science.xyz/technologies...
Join our patient registry here: patients.science.xyz?utm_campaign...
Join our patient registry here: patients.science.xyz?utm_campaign...
Patient Registry | Science Corporation
Join the Science Patient Registry to be considered for participation in our vision loss research studies.
patients.science.xyz
October 31, 2025 at 12:06 AM
Learn more about PRIMA here: science.xyz/technologies...
Join our patient registry here: patients.science.xyz?utm_campaign...
Join our patient registry here: patients.science.xyz?utm_campaign...
@nejm.org last week published results from a landmark clinical trial showing that more than 80% of patients in the trial with this form of macular degeneration gained the ability to read letters, numbers, and words with the PRIMA retinal implant.
science.xyz/news/new-eng...
science.xyz/news/new-eng...
The New England Journal of Medicine Reports Science Corp.’s PRIMA BCI Implant Restores Functional Central Vision to Patients with Geographic Atrophy Caused By Age-Related Macular Degeneration | Scienc...
Science Corporation is a clinical-stage medical technology company.
science.xyz
October 31, 2025 at 12:06 AM
@nejm.org last week published results from a landmark clinical trial showing that more than 80% of patients in the trial with this form of macular degeneration gained the ability to read letters, numbers, and words with the PRIMA retinal implant.
science.xyz/news/new-eng...
science.xyz/news/new-eng...
Learn more about our work on PRIMA here: science.xyz/technologies...
PRIMA Visual Prosthesis | Science Corporation
Science Corporation is a clinical-stage medical technology company.
science.xyz
October 28, 2025 at 4:39 PM
Learn more about our work on PRIMA here: science.xyz/technologies...
Join our patient registry to receive information about availability of treatments that may be relevant to your conditions and updates about our research: patients.science.xyz?utm_campaign...
Patient Registry | Science Corporation
Join the Science Patient Registry to be considered for participation in our vision loss research studies.
patients.science.xyz
October 24, 2025 at 10:24 PM
Join our patient registry to receive information about availability of treatments that may be relevant to your conditions and updates about our research: patients.science.xyz?utm_campaign...
Read more from the Stanford Report here: news.stanford.edu/stories/2025...
Learn more about the landmark clinical trial of PRIMA here: science.xyz/news/new-eng...
Learn more about the landmark clinical trial of PRIMA here: science.xyz/news/new-eng...
Eye prosthesis restores sight to patients with incurable vision loss
In a Stanford Medicine-led clinical trial, a wireless retinal prosthesis enabled patients with advanced macular degeneration to regain enough vision to read books and subway signs.
news.stanford.edu
October 24, 2025 at 10:24 PM
Read more from the Stanford Report here: news.stanford.edu/stories/2025...
Learn more about the landmark clinical trial of PRIMA here: science.xyz/news/new-eng...
Learn more about the landmark clinical trial of PRIMA here: science.xyz/news/new-eng...
Learn more about our work on PRIMA here: science.xyz/technologies...
PRIMA Visual Prosthesis | Science Corporation
Science Corporation is a clinical-stage medical technology company.
science.xyz
October 22, 2025 at 8:05 PM
Learn more about our work on PRIMA here: science.xyz/technologies...
Create a Science Patient Registry account for yourself or a loved one to receive information about availability of our treatments that may be relevant to your conditions and updates about Science's research.
patients.science.xyz?utm_campaign...
patients.science.xyz?utm_campaign...
Patient Registry | Science Corporation
Join the Science Patient Registry to be considered for participation in our vision loss research studies.
patients.science.xyz
October 21, 2025 at 6:43 PM
Create a Science Patient Registry account for yourself or a loved one to receive information about availability of our treatments that may be relevant to your conditions and updates about Science's research.
patients.science.xyz?utm_campaign...
patients.science.xyz?utm_campaign...
@nejm.org published the results of this trial yesterday in a new peer-reviewed original paper.
www.nejm.org/doi/full/10....
www.nejm.org/doi/full/10....
Subretinal Photovoltaic Implant to Restore Vision in Geographic Atrophy Due to AMD | NEJM
Geographic atrophy due to age-related macular degeneration (AMD) is the leading cause
of irreversible blindness and affects more than 5 million persons worldwide. No therapies
to restore vision in ...
www.nejm.org
October 21, 2025 at 6:43 PM
@nejm.org published the results of this trial yesterday in a new peer-reviewed original paper.
www.nejm.org/doi/full/10....
www.nejm.org/doi/full/10....
Sign up for our patient registry to learn more: patients.science.xyz?utm_campaign...
Patient Registry | Science Corporation
Join the Science Patient Registry to be considered for participation in our vision loss research studies.
patients.science.xyz
October 20, 2025 at 4:50 PM
Sign up for our patient registry to learn more: patients.science.xyz?utm_campaign...
This breakthrough underscores Science Corporation’s commitment to developing technologies to improve the quality of life of those with debilitating conditions for which there are no treatment options.
science.xyz/technologies...
science.xyz/technologies...
PRIMA Visual Prosthesis | Science Corporation
Science Corporation is a clinical-stage medical technology company.
science.xyz
October 20, 2025 at 4:50 PM
This breakthrough underscores Science Corporation’s commitment to developing technologies to improve the quality of life of those with debilitating conditions for which there are no treatment options.
science.xyz/technologies...
science.xyz/technologies...
The paper showed that PRIMA restored functional central vision to eligible patients suffering from geographic atrophy due to age-related macular degeneration, a leading cause of blindness affecting more than 5 million people worldwide.
www.nejm.org/doi/10.1056/...
www.nejm.org/doi/10.1056/...
Subretinal Photovoltaic Implant to Restore Vision in Geographic Atrophy Due to AMD | NEJM
Geographic atrophy due to age-related macular degeneration (AMD) is the leading cause of irreversible blindness and affects more than 5 million persons worldwide. No therapies to restore vision in ...
www.nejm.org
October 20, 2025 at 4:50 PM
The paper showed that PRIMA restored functional central vision to eligible patients suffering from geographic atrophy due to age-related macular degeneration, a leading cause of blindness affecting more than 5 million people worldwide.
www.nejm.org/doi/10.1056/...
www.nejm.org/doi/10.1056/...
The paper showed that PRIMA restored functional central vision to eligible patients suffering from geographic atrophy due to age-related macular degeneration, a leading cause of blindness affecting more than 5 million people worldwide.
www.nejm.org/doi/full/10....
www.nejm.org/doi/full/10....
Subretinal Photovoltaic Implant to Restore Vision in Geographic Atrophy Due to AMD | NEJM
Geographic atrophy due to age-related macular degeneration (AMD) is the leading cause
of irreversible blindness and affects more than 5 million persons worldwide. No therapies
to restore vision in ...
www.nejm.org
October 20, 2025 at 4:46 PM
The paper showed that PRIMA restored functional central vision to eligible patients suffering from geographic atrophy due to age-related macular degeneration, a leading cause of blindness affecting more than 5 million people worldwide.
www.nejm.org/doi/full/10....
www.nejm.org/doi/full/10....